CBClair Barber

Clair Barber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Clair Barber has a total of 339 co-authors. Here are the top co-authors by number of shared publications:

  • Kerry Gove

    Clinical and Experimental Sciences, Faculty of Medicine, University Hospital Southampton, Southampton, Hampshire, United Kingdom, SO16 6YD, Southampton, United Kingdom

    13 shared publications
  • Peter Howarth

    Clinical and Experimental Sciences University of Southampton Faculty of Medicine Southampton UK

    13 shared publications
  • Anoop Chauhan

    Respiratory Medicine, Queen Alexandra Hospital, Portsmouth, Hampshire, United Kingdom, PO6 LY, Portsmouth, United Kingdom

    9 shared publications
  • Colin Newell

    National Institute for Health Research (NIHR) Southampton Biomedical Research Centre at University Hospital Southampton NHS Foundation Trust Southampton UK

    9 shared publications
  • Hitasha Rupani

    Respiratory Medicine, Queen Alexandra Hospital, Portsmouth, Hampshire, United Kingdom, PO6 LY, Portsmouth, United Kingdom

    9 shared publications
  • Paddy Dennison

    National Institute for Health Research (NIHR) Southampton Biomedical Research Centre at University Hospital Southampton NHS Foundation Trust, UK; Asthma, Allergy and Clinical Immunology Department, University Hospital Southampton NHS Foundation Trust, UK

    9 shared publications

Latest Publications

  • Open Access

    Species‐level, metagenomic and proteomic analysis of microbe‐immune interactions in severe asthma

    by Maisha F. Jabeen, Nicholas D. Sanderson, Mariaenrica Tinè, Gillian Donachie, Clair Barber, Adnan Azim, Laurie C. K. Lau, Thomas Brown, Ian D. Pavord, Anoop Chauhan, et al.

    Background: The airway microbiome in severe asthma has not been characterised at species‐level by metagenomic sequencing, nor have the relationships between specific species and mucosal immune responses in ‘type‐2 low’, neutrophilic asthma been defined. We performed an integrated species‐level metagenomic data with inflammatory mediators to characterise prevalence of dominant potentially pathogenic organisms and host immune responses.Methods: Sputum and nasal lavage samples were analysed using long‐read metagenomic sequencing with Nanopore and qPCR in two cross‐sectional adult severe asthma cohorts, Wessex (n = 66) and Oxford (n = 30). We integrated species‐level data with clinical parameters and 39 selected airway proteins measured by immunoassay and O‐link.Results: The sputum microbiome in health and mild asthma displayed comparable microbial diversity. By contrast, 23% (19/81) of severe asthma microbiomes were dominated by a single respiratory pathogen, namely H. influenzae (n = 10), M. catarrhalis (n = 4), S. pneumoniae (n = 4) and P. aeruginosa (n = 1). Neutrophilic asthma was associated with H. influenzae, M. catarrhalis, S. pneumoniae and T. whipplei with elevated type‐1 cytokines and proteases; eosinophilic asthma with higher M. catarrhalis, but lower H. influenzae, and S. pneumoniae abundance. H. influenzae load correlated with Eosinophil Cationic Protein, elastase and IL‐10. R. mucilaginosa associated positively with IL‐6 and negatively with FGF. Bayesian network analysis also revealed close and distinct relationships of H. influenzae and M. catarrhalis with type‐1 airway inflammation. The microbiomes and cytokine milieu were distinct between upper and lower airways.Conclusions: This species‐level integrated analysis reveals central, but distinct associations between potentially pathogenic bacteria and airways inflammation in severe asthma.


  • Open Access

    Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma

    by Adnan Azim, Faisal I. Rezwan, Clair Barber, Matthew Harvey, Ramesh J. Kurukulaaratchy, John W. Holloway, Peter H. Howarth

    The measurement of exhaled volatile organic compounds (VOCs) in exhaled breath (breathomics) represents an exciting biomarker matrix for airways disease, with early research indicating a sensitivity to airway inflammation. One of the key aspects to analytical validity for any clinical biomarker is an understanding of the short-term repeatability of measures. We collected exhaled breath samples on 5 consecutive days in 14 subjects with severe asthma who had undergone extensive clinical characterisation. Principal component analysis on VOC abundance across all breath samples revealed no variance due to the day of sampling. Samples from the same patients clustered together and there was some separation according to T2 inflammatory markers. The intra-subject and between-subject variability of each VOC was calculated across the 70 samples and identified 30.35% of VOCs to be erratic: variable between subjects but also variable in the same subject. Exclusion of these erratic VOCs from machine learning approaches revealed no apparent loss of structure to the underlying data or loss of relationship with salient clinical characteristics. Moreover, cluster evaluation by the silhouette coefficient indicates more distinct clustering. We are able to describe the short-term repeatability of breath samples in a severe asthma population and corroborate its sensitivity to airway inflammation. We also describe a novel variance-based feature selection tool that, when applied to larger clinical studies, could improve machine learning model predictions.


  • Open Access

    Nontypeable Haemophilus influenzae infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma

    by Jodie Ackland, Clair Barber, Ashley Heinson, Adnan Azim, David W. Cleary, Myron Christodoulides, Ramesh J. Kurukulaaratchy, Peter Howarth, Tom M. A. Wilkinson, Karl J. Staples

    Background: Nontypeable Haemophilus influenzae (NTHi) is a respiratory tract pathobiont that chronically colonizes the airways of asthma patients and is associated with severe, neutrophilic disease phenotypes. The mechanism of NTHi airway persistence is not well understood, but accumulating evidence suggests NTHi can persist within host airway immune cells such as macrophages. We hypothesized that NTHi infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma.Methods: Bronchoalveolar lavage (BAL) samples from 25 severe asthma patients were assessed by fluorescence in situ hybridisation to quantify NTHi presence. Weighted gene correlation network analysis (WGCNA) was performed on RNASeq data from NTHi‐infected monocyte‐derived macrophages to identify transcriptomic networks associated with NTHi infection.Results: NTHi was detected in 56% of BAL samples (NTHi+) and was associated with longer asthma duration (34 vs 22.5 years, p = .0436) and higher sputum neutrophil proportion (67% vs 25%, p = .0462). WGCNA identified a transcriptomic network of immune‐related macrophage genes significantly associated with NTHi infection, including upregulation of T17 inflammatory mediators and neutrophil chemoattractants IL1B, IL8, IL23 and CCL20 (all p < .05). Macrophage network genes SGPP2 (p = .0221), IL1B (p = .0014) and GBP1 (p = .0477) were more highly expressed in NTHi+ BAL and moderately correlated with asthma duration (IL1B; rho = 0.41, p = .041) and lower prebronchodilator FEV1/FVC% (GBP1; rho = −0.43, p = .046 and IL1B; rho = −0.42, p = .055).Conclusions: NTHi persistence with pulmonary macrophages may contribute to chronic airway inflammation and T17 responses in severe asthma, which can lead to decreased lung function and reduced steroid responsiveness. Identifying therapeutic strategies to reduce the burden of NTHi in asthma could improve patient outcomes.


  • Open Access

    The Detrimental Clinical Associations of Anxiety and Depression with Difficult Asthma Outcomes

    by Wei Chern Gavin Fong, Ishmail Rafiq, Matthew Harvey, Sabina Stanescu, Ben Ainsworth, Judit Varkonyi-Sepp, Heena Mistry, Mohammed Aref Kyyaly, Clair Barber, Anna Freeman, et al.

    Difficult asthma describes asthma in which comorbidities, inadequate treatment, suboptimal inhaler technique and/or poor adherence impede good asthma control. The association of anxiety and depression with difficult asthma outcomes (exacerbations, hospital admissions, asthma control, etc.) is unclear. This study assessed the clinical associations of anxiety and depression with difficult asthma outcomes in patients with a specialist diagnosis of difficult asthma. Using real-world data, we retrospectively phenotyped patients from the Wessex Asthma Cohort of Difficult Asthma (N = 441) using clinical diagnoses of anxiety and depression against those without anxiety or depression (controls). Additionally, we stratified patients by severity of psychological distress using the Hospital Anxiety and Depression Scale (HADS). We found that depression and/or anxiety were reported in 43.1% of subjects and were associated with worse disease-related questionnaire scores. Each psychological comorbidity group showed differential associations with difficult asthma outcomes. Anxiety alone (7.9%) was associated with dysfunctional breathing and more hospitalisations [anxiety, median (IQR): 0 (2) vs. controls: 0 (0)], while depression alone (11.6%) was associated with obesity and obstructive sleep apnoea. The dual anxiety and depression group (23.6%) displayed multimorbidity, worse asthma outcomes, female predominance and earlier asthma onset. Worse HADS-A scores in patients with anxiety were associated with worse subjective outcomes (questionnaire scores), while worse HADS-D scores in patients with depression were associated with worse objective (ICU admissions and maintenance oral corticosteroid requirements) and subjective outcomes. In conclusion, anxiety and depression are common in difficult asthma but exert differential detrimental effects. Difficult asthma patients with dual anxiety and depression experience worse asthma outcomes alongside worse measures of psychological distress. There is a severity-gradient association of HADS scores with worse difficult asthma outcomes. Collectively, our findings highlight the need for holistic, multidisciplinary approaches that promote early identification and management of anxiety and depression in difficult asthma patients.


  • Vulnerability to acid reflux of the airway epithelium in severe asthma

    by Jeanne-Marie Perotin, Gabrielle Wheway, Kamran Tariq, Adnan Azim, Robert A. Ridley, Jonathan A. Ward, James P.R. Schofield, Clair Barber, Peter Howarth, Donna E. Davies, et al.

    Background: Severe asthma is associated with multiple comorbidities, including gastro-oesophageal reflux disease (GORD), which can contribute to exacerbation frequency and poor quality of life. Since epithelial dysfunction is an important feature in asthma, we hypothesised that in severe asthma the bronchial epithelium is more susceptible to the effects of acid reflux.Methods: We developed anin vitromodel of GORD using differentiated bronchial epithelial cells (BECs) from normal or severe asthmatic donors exposed to a combination of pepsin, acid pH and bile acids using a multiple challenge protocol (MCP-PAB). In addition, we analysed bronchial biopsies and undertook RNA sequencing of bronchial brushings from controls and severe asthmatics without or with GORD.Results: Exposure of BECs to the MCP-PAB caused structural disruption, increased permeability, interleukin (IL)-33 expression, inflammatory mediator release and changes in gene expression for multiple biological processes. Cultures from severe asthmatics were significantly more affected than those from healthy donors. Analysis of bronchial biopsies confirmed increased IL-33 expression in severe asthmatics with GORD. RNA sequencing of bronchial brushings from this group identified 15 of the top 37 dysregulated genes found in MCP-PAB treated BECs, including genes involved in oxidative stress responses.Conclusions and clinical implication: By affecting epithelial permeability, GORD may increase exposure of the airway submucosa to allergens and pathogens, resulting in increased risk of inflammation and exacerbations. These results suggest the need for research into alternative therapeutic management of GORD in severe asthma.


  • Open Access

    Sputum processing by mechanical dissociation: A rapid alternative to traditional sputum assessment approaches

    by Clair Barber, Laurie Lau, Jonathan A. Ward, Thomas Daniels, Alastair Watson, Karl J. Staples, Tom M. A. Wilkinson, Peter H. Howarth

    Background: Sputum cytology is currently the gold standard to evaluate cellular inflammation in the airways and phenotyping patients with airways diseases. Sputum eosinophil proportions have been used to guide treatment for moderate to severe asthma. Furthermore, raised sputum neutrophils are associated with poor disease control and impaired lung function in both asthma and COPD and small airways disease in cystic fibrosis. However, induced‐sputum analysis is subjective and resource heavy, requiring dedicated specialist processing and assessment; this limits its utility in most clinical settings. Indirect blood eosinophil measures have been adopted in clinical care. However, there are currently no good peripheral blood biomarkers of airway neutrophils. A resource‐light sputum processing approach could thus help integrate induced sputum more readily into routine clinical care. New mechanical disruption (MD) methods can rapidly obtain viable single cell suspensions from sputum samples.Aims: The aim of this study was to compare MD sputum processing to traditional methods for cell viability, granulocyte proportions and sputum cytokine analysis.Methods: Sputum plugs were split and processed using traditional methods and the MD method, and samples were then compared.Results: The MD method produced a homogeneous cell suspension in 62 s; 70 min faster than the standard method used. No significant difference was seen between the cell viability (p = 0.09), or the concentration of eosinophils (p = 0.83), neutrophils (p = 0.99) or interleukin‐8 (p = 0.86) using MD.Conclusion: This cost‐effective method of sputum processing could provide a more pragmatic, sustainable means of directly monitoring the airway milieu. Therefore, we recommend this method be taken forward for further investigation.


  • New Perspectives on Difficult Asthma; Sex and Age of Asthma-Onset Based Phenotypes

    by Adnan Azim, Anna Freeman, Audrey Lavenu, Heena Mistry, Hans Michael Haitchi, Colin Newell, Yueqing Cheng, Yvette Thirlwall, Matthew Harvey, Clair Barber, et al.


  • Comparison of two published definitions of sputum neutrophilia show clinical measures of disease are more severe in neutrophilic asthma (NA) than non-neutrophilic asthma (NNA) using >40% sputum neutrophils as the definition of disease

    by Clair Barber, Jon Ward, Scott Elliott, Laurie Lau, Adnan Azim, Kerry Gove, Hitasha Rupani, Thomas Brown, Anoop Chauhan, Karl J Staples, et al.

    Background: Sputum neutrophils are associated with poor disease outcome in asthma, yet there is a lack of a concordance for the definition of neutrophilia in asthma. Gaining an agreed definition of NA may guide clinical care Methods: Clinical data was collected from 138 non-eosinophilic asthma patients within the Wessex Severe Asthma Cohort Study. Data were split by two definitions of neutrophilia; >40% sputum neutrophils (1) and >61% sputum neutrophils (2). Differences in NA vs NNA were explored for each definition of neutrophilia using frequency statistics and Mann Whitney U analysis. Results: Conclusion: Sputum neutrophilia is associated with poor clinical outcome in asthma. Using a definition of >40% sputum neutrophils to define neutrophilia generates a more clinically distinct population of NA than a definition of >61% sputum neutrophils in our cohort. 1. Hastie, JACI 125(5): 1028-1036 e101 2. Simpson, Respirology 11(1): 54-61


  • Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma

    by Clair Barber, Adnan Azim, Jon A Ward, Laurie Lau, Kamran Tariq, Paddy Dennison, Benjamin Green, Timothy S C Hinks, Karl J Staples, Peter H Howarth

    Rationale: Severe asthma is a heterogeneous disease with different inflammatory phenotypes based on blood or sputum measures. Increasingly blood eosinophils (Eos) are used to direct therapy choice but there is limited information how stable inflammatory measures in sputum and blood are over time and how they relate. Method: Sputum was successfully induced in 48 severe asthma patients at 2 timepoints within 2 years. At each timepoint a full blood count was completed. Patients were at least 4-weeks clear of exacerbation and considered stable. The percentage of granulocytes were reported and the stability at these two timepoints was assessed using Spearman’s rho. Results: In this cohort the sputum Eos and blood Eos significantly correlated between the two timepoints (sputum r=0.739,p=<0.005, blood r=0.387,p=0.011). There was also a significant correlation between the Eos proportions in the two compartments (mean blood vs mean sputum Eos r=0.563,p=<0.005). In contrast, although blood neutrophils (Neut) significantly correlated between the two timepoints (r=0.664,p=<0.005), there was no significant correlation between sputum Neut (r=0.125,p=0.397). Circulating Neut did not reflect sputum Neut (r=-0.083,p=0.602). No correlation was seen with granulocyte measurements, lung function, asthma control or disease duration. Discussion: These results demonstrate that airway neutrophilic inflammation is more dynamic than eosinophilic inflammation and poorly reflected in peripheral blood. A greater understanding of the underlying factors responsible for airway neutrophilic changes is needed if progress is to be made in addressing this severe asthma phenotype.